Quantifying Hepatic Mitochondrial Fluxes in Humans

ClinicalTrials.gov ID: NCT05305287

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05305287. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Quantitation of Hepatic Mitochondrial Fluxes in Humans With Nonalcoholic Fatty Liver Disease (NAFLD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

In this study the investigators will quantitate hepatic mitochondrial fluxes in T2D patients with NAFL and NASH before and after 16-weeks treatment with the insulin sensitizer pioglitazone

Study identification

NCT ID: NCT05305287
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 4
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Enrollment: 60 participants

Conditions and interventions

Conditions

Interventions

Pioglitazone Drug
Placebo Other

Drug · Other

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 1, 2022 (Actual)
Primary completion: Mar 31, 2027 (Estimated)
Completion: Mar 31, 2027 (Estimated)
Last update posted: Aug 17, 2026

2022 – 2027

United States locations

U.S. sites: 2
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Texas Diabetes Institute - University Health System	San Antonio	Texas	78207	Recruiting
University of Texas Health Science Center at San Antonio	San Antonio	Texas	78229	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05305287, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 17, 2026 · Synced Nov 15, 2026